THE 4TH INSTALLMENT
NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., IN THE SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NDJOU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
THE FOUNDATION OF JUDICIAL CORRUPTION
John Beerbower Esq is a United States Attorney for the DEA. His activities concerning the “Opioid Pandemic,” resulting from doctor overprescribing and pharmacies responsible for dispensing high dosages of “dangerous drugs,” arise from powers based on a foundation of Judicial corruption, resulting in the death of thousands of individuals suffering from chronic disease states. are the center of deception, corruption, and fraud within the Justice Department, which are both profound and unconstitutional, requiring Congressional Oversight and investigation.
Jeff Singer MD, Senior Fellow Cato Institute:
…Today’s Supreme Court (Raun vs United States) decision was a victory for the “good faith” defense. But it was also a victory for physician autonomy, the patient‐doctor relationship, and patients in pain…
Mr. Beerbower, inhumanity, operates within a unique judicial court system that acts as both Civil or Criminal and abides by no Federal Rules of Criminal and Civil Rules of procedures. John Beerbower’s power comes solely from this court, which operates outside Federal Civil rule and further acts as a Federal Criminal court without six amendment protection and a Civil Court without fourth amendment protections.
Yet, John Beerbowers, a sworn United States Attorney, supported by a small cadre of government lawyers, regional office Supervisors, Diversion Investigators, and DEA Agents, and further supported by a cadre of dishonest so-called pharmacists experts who have successfully conducted a mass campaign of disinformation which are ingrained in their sadistic inhumanity toward the patient in pain and their healthcare providers.
2016 CDC THE FOUNDATION MIS-GUIDELINES OF NARCOTIC ANALGESIC MISINFORMATION
According to Larry Aubry1 and B. Thomas Carr2*, in POLICY AND PRACTICE REVIEWS article Front. Pain Res., 04 August 2022, Sec. Pain Research Methods;
- 1Independent Researcher, Hampshire, IL, United States
- 2Carr Consulting, Wilmette, IL, United States
“As part of the U.S. government’s urgent response to the epidemic of overdose deaths (1)” the United States Centers for Disease Control and Prevention (CDC) issued the “CDC Guideline for Prescribing Opioids for the Chronic Pain-United States, 2016 (2)” (guideline) followed by the “CDC Clinical Practice Guideline for Prescribing Opioids–the United States, 2022 (3) (guideline update). ” The guideline and guideline update cites a direct correlation between prescription opioids sales (POS) and opioid treatment admissions (OTA) and prescription opioid deaths (POD), which was based on data from 1999 to 2010. This paper updates those relationships and includes the correlations between prescription opioid sales (POS) and any opioid deaths (AOD) and total overdose deaths (TOD) from 2010 to 2019.”
1. CDC Press Releases. CDC (2016). Available online at: https://www.cdc.gov/media/releases/2016/p0315-prescribing-opioids-guidelines.html
2. CDC Guideline for Prescribing Opioids for Chronic Pain -United States 2016 Morbidity Mortality Weekly Report. (2016). p. 2, 18. Available online at: https://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6501e1.pdf doi: 10.15585/mmwr.rr6501e1 (accessed May 11, 2022).
3. Federal, Register:: Request Access,.. unblock.federalregister.gov. p. 10–11, 108. Available online at: https://www.federalregister.gov/documents/2022/02/10/2022-02802/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioids (accessed May 11, 2022).
Description of data sources
Most importantly, Larry Aubry1 and B. Thomas Carr2*cite;
- 1Independent Researcher, Hampshire, IL, United States
- 2Carr Consulting, Wilmette, IL, United States
“Data limitations have the potential for over or underestimating overdose deaths. The authors of a 2018 report, “Quantifying the Epidemic of Prescription Opioid Overdose Deaths,” with the CDC, acknowledged that systemic errors and omissions in the source data along with the CDC’s methodology for compiling drug-related mortality data “could significantly inflate (27)” prescription opioid overdose death estimates (27, 28). In 2018, the CDC cut their estimates of prescription opioid deaths from 1999 to 2016 by 48,000 or 19.5%, with the 2016 estimates cut by more than 15,000 or 47.3% (27, 28).
Confounding factors impacting the accuracy of overdose deaths are that “multiple drugs are often involved” (27), the source of opioids detected in postmortem blood toxicity screens is not known (e.g., legally prescribed vs. illicitly obtained), among other issues (27, 28). With this occurrence and/or when multiple conditions resulted in an overdose death, a single sequence/cause will be documented based on the physician’s “best medical opinion (29).”
The same data sources that the CDC guideline appears to be based upon were used for this paper. If a Pharmacist does not reasonably believe that the medication is going to be diverted there is no reason not to accept cash.
Currently, the PDMP system at present cannot distinguish between cash, credit, debit or healthcare payment cards. All, of these things come up on the system as cash.
As such, the results of analyses presented here are at least as reliable and subject to the same limitations as what the CDC obtained from their own analyses of 1999–2010 and if they chose to undertake them for the most recent decade of 2010–2019. Thus, the following sources have been applied.”
27. Seth P, Rudd RA, Noonan RK, Haegerich TM. Quantifying the epidemic of prescription opioid overdose deaths. Am J Public Health.(2018) 108:500–2. doi: 10.2105/AJPH.2017.304265
29. Instructions for Completing the Cause-of-Death Section of the Death Certificate. Available online at: https://www.cdc.gov/nchs/data/dvs/blue_form.pdf
A TRIBUNAL OF JUDICIAL DRUG CORRUPTION
A tribunal of judicial corruption led by corrupt Judges and supported by corrupt United States federal prosecutors from the US Department of Justices (DOJ) such as Wayne F. Pratt, Detroit office, Brandy McMillion, and former AUSA Brandon McMillion, who are permitted to operate outside the rule of Federal Rules of Evidence and Procedures.
The corruption is as deep as it is wide and extends through the United States Attorney General and the General offices throughout America and its territories.
WARNINGS TO HEALTHCARE PROVIDERS FROM Cote Law PLLC
DEA litigation can be intricate, expensive, and fraught with risk. Companies in the health care and pharmaceutical industries must rely on the counsel of attorneys with the skill set and expertise to navigate these dangerous waters.
As important, health care organizations need an attorney to craft an effective compliance strategy that will help to avoid litigation in the first place. Cote Law PLLC provides the experienced legal representation that healthcare companies and organizations need.
Led by a former senior-level DEA attorney, Cote Law PLLC’s expertise and commitment to delivering for our clients is a combination that leads to real solutions in both litigation and compliance matt.
According to the National Association Chain Drug Store’s Amicus Brief, Ruan vs United States:
“Pharmacists play a critical role in our nation’s healthcare system, daily ensuring that, among other things, millions of patients receive the medicines they need as well as instructions for safely using them. Whether in independent pharmacies or chain drug stores, pharmacists and their employers share the same mission regarding prescribed treatment: to deliver to patients the medicines that licensed practitioners have determined they need.”
Wayne F.pratt, ESQ
It is said that Wayne F. Pratt, Chief of the Health Care Fraud unit of the U.S. Attorney’s Office for the Eastern District of Michigan, has saved Medicare nearly $1 billion and has done more to fight health care fraud than almost anyone else in the U.S. Department of Justice.“Emboldened by the medically intrusive 2016 CDC Guidelines, he and DEA operatives have deputized themselves with greater powers to raid innocent doctors’ medical practices even more invasively,”
These intrusions keep occurring with nary a whisper from opiohysterical journalists about these onslaughts on innocent narcotic prescribing doctors.” Where is the “free press”? Who speaks for abandoned pain patients? Who speaks for wrongfully imprisoned physicians?
BRANDY MCMILLION, ESQ.
Brandy McMillion Chief Federal Prosecutor of Pain Care Physicians in Michigan….Shelley Neth writes: “What the DEA has done by infiltrating medicine has killed people. People are suffering from deteriorating health due to the inability to live with the pain. Others have had to stop working and have lost their quality of life. None of this was necessary, all of it misdirected and cruel.
I want to send an official complaint to the UN Human Rights Council and would love to do so at a UN Council meeting, just as Native Americans did a few years ago.”
Brandon helms ESQ
AUSA Brandon Helms wanted to be a doctor but didn’t enjoy Chemistry and Biology. Yet, Mr. Helms has a gift of gabb and goes to law school!!! “Former AUSA Brandon Helms quit the US District Attorney’s Office in Detroit before the end of the pain center trial to join a boutique law firm.
He was overheard saying that his future employer lives in a $4,000,000 house in Atlanta, Georgia. All the while accusing the Pain Center physicians of being “greedy” doctors. These people are blind to their hubris and hypocrisy.
So how does Helms, who disliked “the memorization required for a biology,” manage to end up in the United States Attorneys Detroit Office Healthcare Fraud Division, prosecuting physicians, pharmacists, and dentists. ???
THE CONTROLLED SUBSTANCES ACT
The Controlled Substances Act (CSA) and its implementing regulations established a closed system of distribution to ensure appropriate medical care and to maintain the integrity of the system through an accountability process.
One of the most important principles underlying the CSA and its implementing regulations is that to be valid, every prescription for a controlled substance must be based on a determination by an individual practitioner that the dispensing of the controlled substance is for a legitimate medical purpose in the usual course of professional practice. United States v. Moore, 423 U.S.C. 122 (1975) and 21 CFR 1306.04(a).
Federal regulations do not define the term legitimate medical purpose nor do they set forth the standards of medical practice. It is up to each DEA- registered practitioner authorized by DEA to do so, to treat patients according to his or her professional medical judgment in accordance with a standard of medical practice that is generally recognized and accepted in the United States.
DEA has not promulgated any new regulations regarding the treatment of pain. Federal law and DEA regulations do not impose a specific quantitative minimum or maximum limit on the amount of medication that a practitioner may prescribe on a single prescription or the duration of treatment intended for a particular patient.
“THE COWARD NEVER STARTED; THE WEAK DIED ALONG THE WAY, ONLY THE STRONG SURVIVED”
THE CHAPMAN LAW GROUP PENDING PETITION OF CERTIORARI UNITED STATES SUPREME COURT
SUNTREE PHARMACY AND SUNTREE MEDICAL VS. UNITED STATES DRUG ENFORCEMENT
“On October 5, 2016, the DEA issued Suntree Pharmacy an Order to Show Cause (“OSC”). R. 1. The OSC alleged that Suntree filled prescriptions in contravention of its corresponding responsibility under 21 C.F.R. § 1306.04(a). R. 1 at 2. Specifically, the OSC claimed that Suntree violated this responsibility by “repeatedly fill[ing] controlled substance prescriptions that contained multiple red flags of diversion and/or abuse without addressing or resolving those red flags and under the circumstances indicating that the pharmacists were willfully blind or deliberately ignorant of the prescriptions illegitimacy.”
RED FLAGS – COCKTAILS, PATTERN PRESCRIBING
Pain is a complex and subjective experience initiated by an unpleasant (or noxious) stimulus associated with actual or potential tissue damage. Pain Management is a very complex issue. More often than not, in chronic (non-acute) pain, comorbidities need to be addressed. Therefore, when practitioners find a combination of medications that successfully treat chronic pain, they are reluctant to stray from that protocol. It’s akin to other protocols that are used in medicine that address chronic conditions, such as cancer protocols, ALS protocols, hypertension step-care therapy, anti-coagulation protocols, and others.
Typically, there is inflammation, and therefore, non-steroidal anti-inflammatories are used. Patients often experience anxiety, so anti-anxiety agents such as benzodiazepines or tricyclics are used. In nociceptive pain, Gabapentin is often the first drug of choice. In lower back pain, whose underlying causes can differ from each other, the presentation of muscle spasm or hypersensitivity, muscle relaxers such as cyclobenzaprine, metaxalone, baclofen, carisoprodol, or others represent standard therapy.
Pharmacists, who are widely trusted to act in good faith and should only face CSA liability, are consistently ranked among the most honest and ethical professionals.
It is unreasonable to expect a Diversion Investigator to completely understand these complex issues with their 12-week course when Physicians and Pharmacists require years of training to make adequate choices in this arena.
In sum, the expansive misinterpretations proposed by DOJ would undermine the CSA by threatening pharmacists’ vital role in our nation’s healthcare system.
In resolving the questions raised in this case, the Court should not ignore the potential impact its rulings may have on pharmacists, nor should it construe the CSA and its implementing regulations in any way to undercut the protections they provide pharmacists from unwarranted liability.
FOR NOW, YOU ARE WITHIN
- American Agony; The Opioid War Against Patients in Pain, by Helen Borel, RN, PhD
$10, $15, $20, $25,$50, $75, 175, $500. OR MORE TO CASH APP:$docnorm
So, Donate to the “Pharmacist For Healthcare Legal Defense Fund,”
LOW HANGING FRUIT